fda0134e90b3a62432f289533ac9a750:7fb7d8249134b19606f4d377480b2192fe44e94700a707a2ae2bd9d0c70698444ab0acd4465480e16be7467074542c38b731fb0d6132fe0c0c04481449f9cd093826a4ae9b9d295764056afeffd7bf98adac7d7a31dbab52de5a93539bdd626eb645f4a08731a1a71aaeb38a8dd1ae4d2d9127ce56fe3aa71e09d2da2b0f17ae03ac907c7998b1c0aa862a84c59bea48314ec3ae668986afc0043e6183c45cf6ae464844c7baa819bc474ba41383b153a574fcc248e9347e888506e62151705c6932d6fd60ff53393b741620304a506508798fc3f7e384706570e9dfbeb250d8731e87d0d0aa2b84ba6ed907f8f6eeb6b79065003e71ff14b22881949d6d14a6fa7c585132246d163a42f816d27d81a153a684b3ec7bc914226a03f9a2fa6dc959c8764da23311319721c0dd3d3642521195661025d1f631834a585b168289dc7504529f43480afb3e367d9cd6e35d294291ec69ef3c8ff8548dd4289813e6f404cbdd1c90e4b30421f0be2369534975a035d0ca5525e944c56a3d310ed0673891fd4adf5f121b7d2a551c016392fb137d59be4651ab2752ee4666f6fb5f1d5d4b5b024529cc8035